• Home
  • Study Details
Open

Nutrition, Eating, and Mealtimes for Older Adults with Myelodysplastic Syndromes and Acute Myeloid Leukemia, and their Care Partners

This is a study for people diagnosed with Acute Myeloid Leukemia and Myelodysplastic Syndromes who are receiving treatment with hypomethylating agents and Venetoclax. Specifically, we want to learn more about nutrition, eating, and mealtimes for older adults (age 60+) with these conditions and their care partners. Care partners can be a spouse, family member, or friend helping a patient with AML/MDS. We want to understand nutrition, eating, and mealtimes over time throughout the first two cycles of treatment. We also want to learn more about the quality of life for patients and care partners.

Age & Gender

  • 60 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

At the beginning of Cycle 1 and Cycle 2 treatment, you will meet with a member of the study team to fill out questionnaires and tests related to your quality of life, diet, nutrition, and ability to complete daily tasks/function. Care partners will meet with a member of the study team to fill out questionnaires related to their quality of life, nutrition, and caregiving. Patients and care partners will also complete a 30-45 minute interview about eating and mealtimes. Every two weeks through Cycles 1 and 2, patients and care partners will complete some assessments for quality of life and nutrition, along with an interview about eating and mealtimes.

Incentives

Parking voucher for each day of data collection, and gift cards from $15-30 per data collection

In-person visits:
5-9
Phone or online visits:
Optional, 3-7
Total length of participation:
About 2-4 months, through the first 2 cycles of treatment.

Looking for Specific Volunteers

Able to participate:

  • You have been diagnosed with Acute Myeloid Leukemia or Myelodysplastic Syndromes
  • You are receiving treatment with hypomethylating agents (such as azacitidine) and Venetoclax
  • You are a care partner of someone with AML/MDS receiving these treatments
  • You are able to understand and speak English

Not eligible if:

  • You have advanced cognitive impairments, or otherwise not able to consent for research

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Victoria Crowder
School of Nursing

Study Type

Behavioral or Social
Observational

Study Topics

Aging
Blood Conditions
Cancer (Leukemia)
Eating, Nutrition, and Metabolism

IRB Number

23-0976

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research